MONACE fosinopril  sodium 20 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

monace fosinopril sodium 20 mg tablet blister pack

alphapharm pty ltd - fosinopril sodium, quantity: 20 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; hyprolose; crospovidone; glyceryl behenate - monace is indicated for the treatment of mild to moderate hypertension. monace is effective alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of monace and diuretics used concomitantly are approximately additive. data have not been provided to support the use of monace in severe or renovascular hypertension. heart failure: monace is indicated for the management of heart failure when added to conventional therapy, including diuretics.

MONACE fosinopril  sodium 10 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

monace fosinopril sodium 10 mg tablet blister pack

alphapharm pty ltd - fosinopril sodium, quantity: 10 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; hyprolose; crospovidone; glyceryl behenate - monace is indicated for the treatment of mild to moderate hypertension. monace is effective alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of monace and diuretics used concomitantly are approximately additive. data have not been provided to support the use of monace in severe or renovascular hypertension. heart failure: monace is indicated for the management of heart failure when added to conventional therapy, including diuretics.

DILART HCT 160/12.5 mg valsartan 160 mg/ hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dilart hct 160/12.5 mg valsartan 160 mg/ hydrochlorothiazide 12.5 mg film-coated tablet blister pack

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; povidone; sodium lauryl sulfate; crospovidone; magnesium stearate; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide red; macrogol 400 - dilart?hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

DILART HCT 320/12.5 mg valsartan 320 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dilart hct 320/12.5 mg valsartan 320 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

alphapharm pty ltd - valsartan, quantity: 320 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; povidone; crospovidone; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; purified talc; iron oxide red; macrogol 4000; iron oxide black - dilart?hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

DILART HCT 160/25 mg valsartan 160 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dilart hct 160/25 mg valsartan 160 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack

alphapharm pty ltd - hydrochlorothiazide, quantity: 25 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; pregelatinised maize starch; microcrystalline cellulose; sodium lauryl sulfate; crospovidone; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 8000; purified talc; iron oxide yellow; iron oxide red; iron oxide black - dilart?hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

DILART HCT 320/25 mg valsartan 320 mg/ hydrochlorothiazide 25 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dilart hct 320/25 mg valsartan 320 mg/ hydrochlorothiazide 25 mg film-coated tablet blister pack

alphapharm pty ltd - hydrochlorothiazide, quantity: 25 mg; valsartan, quantity: 320 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; lactose monohydrate; sodium lauryl sulfate; pregelatinised maize starch; microcrystalline cellulose; crospovidone; povidone; titanium dioxide; hypromellose; macrogol 8000; purified talc; iron oxide yellow - dilart?hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

DILART HCT 80/12.5 mg valsartan 80 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dilart hct 80/12.5 mg valsartan 80 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; colloidal anhydrous silica; pregelatinised maize starch; sodium lauryl sulfate; lactose monohydrate; povidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; purified talc; iron oxide yellow; iron oxide red - dilart?hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

FOSIPRIL 20 fosinopril sodium 20  mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

fosipril 20 fosinopril sodium 20 mg tablet blister pack

arrotex pharmaceuticals pty ltd - fosinopril sodium, quantity: 20 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; crospovidone; povidone; glyceryl behenate - hypertension: treatment of mild to moderate hypertension. fosinopril is effectine alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of fosinopril and diuretics used concomitantly are approximately additive. data have not been provided to support the use of fosinopril in severe or renovascular hypertension. heart failure: management of heart failure when added to conventional therapy, including diuretics.

FOSIPRIL 10 fosinopril sodium 10  mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

fosipril 10 fosinopril sodium 10 mg tablet blister pack

arrotex pharmaceuticals pty ltd - fosinopril sodium, quantity: 10 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; crospovidone; povidone; glyceryl behenate - hypertension: treatment of mild to moderate hypertension. fosinopril is effectine alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of fosinopril and diuretics used concomitantly are approximately additive. data have not been provided to support the use of fosinopril in severe or renovascular hypertension. heart failure: management of heart failure when added to conventional therapy, including diuretics.